PMGC Holdings Inc. Files 8-K with Financials

Ticker: ELAB · Form: 8-K · Filed: Feb 19, 2025 · CIK: 1840563

Sentiment: neutral

Topics: 8-K, financial-statements, disclosure

TL;DR

PMGC Holdings Inc. (formerly Elevai Labs) filed an 8-K on Feb 19, 2025, with financial updates.

AI Summary

PMGC Holdings Inc. filed an 8-K on February 19, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits as of February 18, 2025. The company, formerly known as Elevai Labs Inc. and Reactive Medical Labs Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing provides updated financial information and disclosures, which are crucial for investors to assess the company's current financial health and regulatory compliance.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, primarily containing financial statements and disclosures, without immediate significant operational or financial news.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits as of February 18, 2025.

What were the previous names of PMGC Holdings Inc.?

PMGC Holdings Inc. was formerly known as Elevai Labs Inc. and Reactive Medical Labs Inc.

In which state is PMGC Holdings Inc. incorporated?

PMGC Holdings Inc. is incorporated in Nevada.

What is the Standard Industrial Classification code for PMGC Holdings Inc.?

The Standard Industrial Classification code for PMGC Holdings Inc. is 2834, which corresponds to Pharmaceutical Preparations.

What is the business address of PMGC Holdings Inc.?

The business address of PMGC Holdings Inc. is c/o 120 Newport Center Drive, Ste. 250, Newport Beach, CA 92660.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 19, 2025 regarding PMGC Holdings Inc. (ELAB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing